Cargando…
Development of [(18)F]AmBF(3) Tetrazine for Radiolabeling of Peptides: Preclinical Evaluation and PET Imaging of [(18)F]AmBF(3)-PEG(7)-Tyr(3)-Octreotide in an AR42J Pancreatic Carcinoma Model
[Image: see text] Radiolabeled peptides have emerged as highly specific agents for targeting receptors expressed in tumors for therapeutic and diagnostic purposes. Peptides developed for positron emission tomography (PET) are typically radiolabeled using prosthetic groups or bifunctional chelators f...
Autores principales: | Otaru, Sofia, Paulus, Andreas, Imlimthan, Surachet, Kuurne, Iida, Virtanen, Helena, Liljenbäck, Heidi, Tolvanen, Tuula, Auchynnikava, Tatsiana, Roivainen, Anne, Helariutta, Kerttuli, Sarparanta, Mirkka, Airaksinen, Anu J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305971/ https://www.ncbi.nlm.nih.gov/pubmed/35709482 http://dx.doi.org/10.1021/acs.bioconjchem.2c00231 |
Ejemplares similares
-
Pharmacokinetics, radiation dosimetry, acute toxicity and automated synthesis of [(18)F]AmBF(3)-TATE
por: Lau, Joseph, et al.
Publicado: (2020) -
Evaluation of Organo [(18)F]Fluorosilicon Tetrazine as a Prosthetic Group for the Synthesis of PET Radiotracers
por: Otaru, Sofia, et al.
Publicado: (2020) -
Synthesis and Evaluation of [(18)F]FEtLos and [(18)F]AMBF(3)Los as Novel (18)F-Labelled Losartan Derivatives for Molecular Imaging of Angiotensin II Type 1 Receptors
por: Sahylí Ortega Pijeira, Martha, et al.
Publicado: (2020) -
Radiolabelling of peptides with tetrazine ligation based on the inverse electron-demand Diels–Alder reaction: rapid, catalyst-free and mild conversion of 1,4-dihydropyridazines to pyridazines
por: Otaru, Sofia, et al.
Publicado: (2023) -
Metabolism of a Bioorthogonal PET Tracer Candidate
[(19)F/(18)F]SiFA-Tetrazine in Mouse Liver Microsomes:
Biotransformation Pathways and Defluorination Investigated by UHPLC-HRMS
por: Otaru, Sofia, et al.
Publicado: (2020)